
Current and future randomized trials of intracerebral hemorrhage
Antithrombotics and ICH
Endovascular treatment
Wissenschaftliche Leitung
Klinikum Siegen
Klinik für Neurologie
Chefarzt
Referent:in
Klinikum Frankfurt Höchst
Klinik für Neurologie
Chefarzt
Referent:in
Bispebjerg og Frederiksberg Hospital
Neurologisk Afdeling
Chefärztin
Referent:in
Tyks Neurokeskus TE5
Division of Clinical Neurosciences
Chief Physician
In this broadcast, you will hear all the highlights and key updates from the European Stroke Organisation Conference 2021:
At the beginning, Prof. Thorsten Steiner, Frankfurt/Germany, addresses the topic of Current and future randomized trials of intracerebral hemorrhage. Among other things, he discusses mechanisms and treatment targets of ICH and novel and emerging therapeutic approaches.
The second contribution on Antithrombotics and ICH follows by Prof. Hanne Christensen, Copenhagen/Denmark. She presents data from several studies, these include the ANNEXA-4 and the APACHE-AF study.
The final talk will be given by Prof. Risto Roine, Turku/Finland, with the topic Endovascular treatment. He introduces the Flying Intervention Team and compares different treatment options using trial data (including from the MR CLEAN MED and SWIFT DIRECT trials).
Kanal
Indikationen
intracerebral hemorrhage
major bleeding
Stroke
Wirkstoffe
Andexanet alfa
antiplatelets
antithrombotics
Apixaban
ASA
Aspirin
Clopidogrel
Dabigatran
DOAC
Fxa
Heparin
OAC
Rivaroxaban
t-PA
VKA
Schlagworte
ANNEXA-4
APACHE-AF
Apollo-device
Artemis-device
Axonpen-device
DEVT
DIRECT-MT
Endovascular therapy
EVT
Flying Intervention Team
hematoma expansion
Mechanical thrombectomy
mr clean med
MR CLEAN-NOIV
MT
RESTART
SKIP-DIRECT
SoSTART
SWIFT-DIRECT